Page last updated: 2024-08-24

glucose, (beta-d)-isomer and Nausea

glucose, (beta-d)-isomer has been researched along with Nausea in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chou, YM; Goh, ZNL; Lin, CC; Seak, CJ; Seak, CK; Seak, JC1
Amini, S; Eriksson, JW; Johnsson, E; Lundkvist, P; Pereira, MJ; Sjöström, CD1

Trials

1 trial(s) available for glucose, (beta-d)-isomer and Nausea

ArticleYear
Dapagliflozin once-daily and exenatide once-weekly dual therapy: A 24-week randomized, placebo-controlled, phase II study examining effects on body weight and prediabetes in obese adults without diabetes.
    Diabetes, obesity & metabolism, 2017, Volume: 19, Issue:1

    Topics: Adipose Tissue; Adult; Aged; Benzhydryl Compounds; Blood Glucose; Blood Pressure; Body Composition; Body Weight; Double-Blind Method; Drug Therapy, Combination; Exenatide; Female; Glucose Intolerance; Glucosides; Humans; Hypoglycemic Agents; Injections, Subcutaneous; Magnetic Resonance Imaging; Male; Middle Aged; Nausea; Obesity; Peptides; Prediabetic State; Treatment Outcome; Venoms; Weight Loss

2017

Other Studies

1 other study(ies) available for glucose, (beta-d)-isomer and Nausea

ArticleYear
Euglycemic diabetic ketoacidosis caused by dapagliflozin: A case report.
    Medicine, 2018, Volume: 97, Issue:25

    Topics: Abdominal Pain; Benzhydryl Compounds; Diabetes Mellitus, Type 2; Diabetic Ketoacidosis; Dyspnea; Fatigue; Female; Glucosides; Humans; Hypoglycemic Agents; Middle Aged; Nausea; Vomiting

2018